Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
In $285M deal, Novo taps Ascendis to help create monthly GLP-1
Novo Nordisk has signed a $285 million biobucks deal with Ascendis to help the Wegovy manufacturer reduce GLP-1 dosing frequency.
James Waldron
Nov 4, 2024 8:43am
Jade pockets Aerovate in reverse merger
Oct 31, 2024 3:03pm
AbbVie pays $65M for options on EvolveImmune's T-cell engagers
Oct 31, 2024 10:00am
Biogen buys in to molecular glues with deal worth up to $1.45B
Oct 30, 2024 10:50am
Crescent inks GlycoMimetics merger, securing listing and $200M
Oct 29, 2024 10:20am
GSK aims to extend lupus dominance via $300M T-cell engager deal
Oct 29, 2024 8:00am